Valente Nancy 4
4 · Myovant Sciences Ltd. · Filed Nov 9, 2021
Insider Transaction Report
Form 4
Valente Nancy
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-11-05+36,892→ 36,892 totalExercise: $22.71Exp: 2031-11-04→ Common Shares (36,892 underlying)
Footnotes (1)
- [F1]1/3rd of the shares underlying the option vest and become exercisable on November 5, 2022, with the balance of the shares vesting in eight equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the vesting date.